Human Xtensions: Why 2025 Gross Profit Does Not Describe a Live Business
Human Xtensions ended 2025 with reported gross profit of NIS 1.53 million even though revenue was zero. Almost all of that number came from reversing an inventory impairment and remeasuring assets held for sale, not from a business that was still selling products.
Why The Gross Profit Needs To Be Isolated
The main article already made the broader point: Human Xtensions ended 2025 as a public shell moving from a sold business into a business that had not yet arrived. This follow-up isolates one narrower issue because it is easy to misread on a quick pass. The 2025 gross profit looks like a sign of operating life, but in practice it is mostly accounting cleanup around the asset sale.
The raw numbers are sharp. In the income statement, 2025 revenue is zero, yet gross profit is still reported at NIS 1.53 million. That is not a small technical quirk. It means the gross line is no longer measuring sales less cost of sales. It is largely measuring a valuation update on assets that had already been classified as held for sale.
| Item | 2025, NIS thousands | What it really means |
|---|---|---|
| Revenue | 0 | No live product sales |
| Reversal of inventory impairment | 1,465 | A write-up of inventory that had been cut down in 2024 |
| Cost-of-sales line | 65 | The only remaining item is a warranty movement, not production or sales activity |
| Reported gross profit | 1,530 | An accounting number, not a read on a live operating business |
That distinction matters immediately. Note 17A shows no material purchases, no labor cost in cost of sales, and no movement in work in progress or finished goods. The only thing left inside the 2025 cost-of-sales section is a NIS 65 thousand warranty item. In other words, even the small residual piece around the gross line is not live operating activity. It is a leftover accounting item after the operating business was dismantled.
What Actually Sat Inside The Gross Line
The mechanism starts in 2024. That year the company recognized an inventory impairment of NIS 2.908 million, and the inventory that remained at year-end, NIS 1.459 million, was reclassified as held for sale. In 2025 the company updated the fair value of the assets held for sale against expected consideration in the asset sale and recognized a NIS 1.465 million reversal of inventory impairment.
That chart is the core of the thesis. Inventory did not generate gross profit here because the company sold more systems to customers. It moved from a heavily impaired 2024 carrying value to a higher value that was derecognized inside the sale transaction. That is why almost the entire 2025 gross profit is really the reversal of a prior write-down rather than evidence that the old business had resumed healthier economics.
The point gets stronger when Note 8 is read together with Note 17A. Note 8 records the reversal. Note 17A shows that the 2025 cost-of-sales section no longer contains ordinary operating inputs. The gross line effectively became a channel through which the accounting caught up with the sale value of assets that were on their way out.
The Half-Year Split Makes The Distortion Obvious
Regulation 10A in Part D splits 2025 into two six-month periods, and that makes the issue even clearer. The entire annual gross profit, NIS 1.53 million, sits in the first half of the year. In the second half, gross profit is zero.
That timing matters because Note 13 says the first closing of the asset sale took place only on August 18, 2025, after an amendment that merged the first two payments. So the half-year split says something quite specific: the positive gross result was already booked in the first half, before the first closing legally happened. This is not the pattern of an operating business still selling through the second half. It is the pattern of a held-for-sale remeasurement running through the gross line.
The operating line tells the same story. The first half still shows operating profit of NIS 522 thousand. The second half falls back to an operating loss of NIS 1.722 million, with zero gross profit and continued public-shell overhead. Once the accounting cleanup leaves the frame, there is no underlying operating business left generating steady operating earnings.
Even Below Gross Profit, This Is Still Not A Live Business
Trying to move the discussion below gross profit does not really help. Note 12 shows total consideration of NIS 3.329 million from the asset sale, against net assets derecognized of NIS 2.919 million and transaction expenses of NIS 337 thousand. The line that ultimately remained was only NIS 73 thousand of other income.
That means there is no hidden new earnings engine below the gross line either. There is an asset disposal, there are transaction costs, and there is only a small residual benefit left in other income. That matters. A transition-year filing like this can tempt readers into saying: fine, maybe gross profit is noisy, but at least the sale itself created a meaningful bottom-line gain. Not really. After transaction costs, the remaining P&L benefit is small.
The result is a consistent picture. The cleaner 2025 income statement is not evidence of a healthier residual business because no residual operating business is actually left. It is a report in which accounting closed the gap between distressed carrying values and sale values while the company itself was left with a public shell and maintenance-level overhead.
What Should Be Measured From Here
If 2025 is not describing a live business, the monitoring framework has to move elsewhere. First, investors should track collection of the remaining sale consideration and completion of the still-open sale steps. Second, they should track how much time the shell really has without a new activity and without fresh funding. Third, they should wait for the point at which a future report contains live revenue from a new activity, if that ever happens.
That is exactly why the 2025 gross profit can mislead more than it helps. It looks like a quality-of-business line. In practice it belongs to the world of held-for-sale accounting, impairment reversal, and the pricing of an exit from the old business. Anyone looking to this line for evidence of selling power, pricing, demand, or product margin is looking at the wrong line.
Bottom Line
Human Xtensions' 2025 gross profit does not describe a live business. It describes what happened to inventory and asset accounting right before and right after the old operating business was sold.
So the right reading of 2025 is not “the company recovered gross profitability.” It is “the company cleaned up the balance sheet and the income statement after exiting the old business.” Once those two ideas are separated, the next monitoring points become obvious: not the old gross margin, but whether the shell, the cash balance, and the next deal can actually turn into a new business that sells something real.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.